Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Cancer. 2014 Jan 01; 120(1):52-60.